Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Henry Schein, Inc. Add to portfolio

NAS:HSIC, Nov 21, 04:22 UTC

Latest NAS:HSIC News

Filter your feed

Apply Filter

Yesterday


News

Henry Schein to Present at Nasdaq’s 41st Investor Conference

HSIC

Henry Schein, Inc. (HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at Nasdaq’s 41st Investor Conference on Wednesday, December 4, 2019, at 8:45 a.m. GMT at The May Fair Hotel in London. About Henry Schein, Inc. Henry Schein, Inc. (HSIC) is a solutions company for health care professionals powered by a network of people and technology. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items. The Company's sales from continuing operations reached $9.4 billion in 2018, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995. For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
  • Science
  • Technology

Friday, November 15


News

Daiwa Securities Group Inc. Buys 1,380 Shares of Henry Schein, Inc. (NASDAQ:HSIC) – Mitchell Messenger

HSIC

Daiwa Securities Group Inc. grew its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 25.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). Piper Jaffray Companies increased their price objective on shares of Henry Schein from $72.00 to $80.00 and gave the company an “overweight” rating in a research note on Monday. Following the completion of the sale, the chief executive officer now owns 344,554 shares of the company’s stock, valued at $23,260,840.54. Henry Schein announced that its Board of Directors has authorized a stock buyback plan on Thursday, October 31st that permits the company to repurchase $400.00 million in shares.

Read Full Details

Topics:
  • Business
  • Financial

Thursday, November 14


News

Global Orthodontic Retainer Market 2019 – DENLAB , Protec Dental , Ormco , Dentsply , 3M Unitek , Henry Schein , – Daily Industry Journal

XRAY HSIC

Global Orthodontic Retainer Market 2019 – DENLAB , Protec Dental , Ormco , Dentsply , 3M Unitek , Henry Schein. The Global Orthodontic Retainer Market 2019 report is based on key players, which are combined by market share, history of growth and Industry forecasts, it provides in-detailed information, basic needs of the market, and the report shows the how this market is growing Globally. The main regions that contribute to the worldwide Orthodontic Retainer Market 2019 are United States, Europe, Japan, China, India, Southeast Asia. Chapter 1, to describe worldwide Orthodontic Retainer Market 2019 Introduction, product scope, market overview, market opportunities, market risk, market driving force;.

Read Full Details

Topics:
  • Business
  • Financial
News

Brokerages Expect Henry Schein, Inc. (NASDAQ:HSIC) Will Announce Quarterly Sales of $2.64 Billion – GCR

HSIC

According to Zacks, analysts expect that Henry Schein will report full year sales of $9.95 billion for the current fiscal year, with estimates ranging from $9.93 billion to $9.99 billion. For the next year, analysts forecast that the business will report sales of $10.30 billion, with estimates ranging from $10.26 billion to $10.38 billion. The company has a market cap of $9.89 billion, a price-to-earnings ratio of 18.42, a price-to-earnings-growth ratio of 2.65 and a beta of 0.85. Henry Schein declared that its Board of Directors has initiated a stock repurchase plan on Thursday, October 31st that permits the company to repurchase $400.00 million in outstanding shares. Finally, NN Investment Partners Holdings N.V. bought a new stake in shares of Henry Schein during the second quarter valued at approximately $687,000.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, November 13


News

Henry Schein (NASDAQ:HSIC) Announces Earnings Results – Mitchell Messenger

HSIC

Henry Schein updated its FY19 guidance to $3.41-3.47 EPS and its FY20 guidance to $3.65-3.75 EPS. The company has a market cap of $10.11 billion, a price-to-earnings ratio of 16.47, a PEG ratio of 2.71 and a beta of 0.85. Finally, UBS Group cut their price target on Henry Schein from $57.00 to $56.00 and set a “sell” rating on the stock in a research note on Tuesday. Henry Schein announced that its Board of Directors has authorized a share repurchase plan on Thursday, October 31st that authorizes the company to buyback $400.00 million in outstanding shares.

Read Full Details

Topics:
  • Business
  • Financial

Monday, November 11


News

Global Dental Braces Market Research Report 2019-2025 Henry Schein, 3M Unitek, GC Orthodontics – Bishop's Cleeve Bulletin

HSIC

In addition to this, the Dental Braces market study report is segmented by application/end-users, elite industry manufacturers, product types, geographic regions and more. According to the study, the Dental Braces market has been witnessing growth at a remarkable rate over the last few years which is backed by vast availability of key factors that adds extensibility in the international market. Prominent players of Dental Braces market studied in this report are:. The Global Dental Braces market has been analyzed on the basis of distinct regions like Europe, Latin America, Middle East & Africa, North America, Asia Pacific and Rest of the world.

Read Full Details

Topics:
  • Business
  • Financial

Saturday, November 09


News

Henry Schein, Inc. (NASDAQ:HSIC) Stock Position Cut by BlackRock Inc. – TechNewsObserver

HSIC

BlackRock Inc. lessened its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 4.8% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,842,892 shares of the company’s stock after selling 546,796 shares during the period. Longview Partners Guernsey LTD now owns 15,527,241 shares of the company’s stock valued at $1,085,354,000 after buying an additional 2,117,869 shares in the last quarter. In other Henry Schein news, Vice Chairman James P. Breslawski sold 6,856 shares of the firm’s stock in a transaction dated Wednesday, November 6th.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, November 06


News

CIBC Asset Management Inc Raises Stake in Henry Schein, Inc. (NASDAQ:HSIC) – Riverton Roll

HSIC

CIBC Asset Management Inc raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 9.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The company has a market cap of $9.38 billion, a price-to-earnings ratio of 16.40, a PEG ratio of 2.45 and a beta of 0.85. Henry Schein declared that its board has authorized a share buyback plan on Thursday, October 31st that permits the company to buyback $400.00 million in outstanding shares. Zacks Investment Research raised shares of Henry Schein from a “sell” rating to a “hold” rating and set a $66.00 price target on the stock in a research note on Monday, October 14th.

Read Full Details

Topics:
  • Business
  • Financial

Tuesday, November 05


News

Henry Schein (NASDAQ:HSIC) Updates FY20 Earnings Guidance – Mitchell Messenger

HSIC

The company provided earnings per share guidance of $3.65-3.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.73. The stock has a market cap of $9.38 billion, a price-to-earnings ratio of 16.34, a PEG ratio of 2.45 and a beta of 0.85. Henry Schein declared that its Board of Directors has approved a stock buyback program on Thursday, October 31st that allows the company to buyback $400.00 million in shares. Zacks Investment Research upgraded shares of Henry Schein from a sell rating to a hold rating and set a $66.00 target price for the company in a report on Monday, October 14th.

Read Full Details

Topics:
  • Business
  • Financial
News

Henry Schein (HSIC) Q3 Earnings Top Estimates, Revenues Lag

HSIC

Henry Schein, Inc. HSIC reported adjusted earnings per share (EPS) from continuing operations of 90 cents in the third quarter of 2019, up 15.4% year over year. Excluding $21.7 million in corporate revenues from product sales to Covetrus under the transition services agreement related to Henry Schein’s Animal Health spin-off, normalized internal sales growth in local currencies was 3%. It expects adjusted EPS in the range of $3.41 to $3.47(compared to earlier-provided range of $3.38-$3.50), reflecting 8-9% growth from 2018. Henry Schein carries a Zacks Rank #3 (Hold). Some better-ranked companies, which posted solid results this earnings season, are Edwards Lifesciences EW, Thermo Fisher Scientific TMO and ResMed RMD, each carrying a Zacks Rank #2 (Buy).

Read Full Details

Topics:
  • Business
  • Financial